Literature DB >> 17940216

Muscle-specific overexpression of the type 1 IGF receptor results in myoblast-independent muscle hypertrophy via PI3K, and not calcineurin, signaling.

Lebris S Quinn1, Barbara G Anderson, Stephen R Plymate.   

Abstract

The insulin-like growth factors (IGF-I and IGF-II), working through the type 1 IGF receptor (IGF-1R), are key mediators of skeletal muscle fiber growth and hypertrophy. These processes are largely dependent on stimulation of proliferation and differentiation of muscle precursor cells, termed myoblasts. It has not been rigorously determined whether the IGFs can also mediate skeletal muscle hypertrophy in a myoblast-independent fashion. Similarly, although the phosphatidylinositol 3-kinase (PI3K) and calcineurin signaling pathways have been implicated in skeletal muscle hypertrophy, these pathways are also involved in skeletal myoblast differentiation. To determine whether the IGFs can stimulate skeletal muscle hypertrophy in a myoblast-independent fashion, we developed and validated a retroviral expression vector that mediated overexpression of the human IGF-1R in rat L6 skeletal myotubes (immature muscle fibers), but not in myoblasts. L6 myotubes transduced with this vector accumulated significantly higher amounts of myofibrillar proteins, in a ligand- and receptor-dependent manner, than controls and demonstrated significantly increased rates of protein synthesis. Stimulation of myotube hypertrophy was independent of myoblast contributions, inasmuch as these cultures did not exhibit increased levels of myoblast proliferation or differentiation. Experiments with PI3K and calcineurin inhibitors indicated that myoblast-independent myotube hypertrophy was mediated by PI3K, but not calcineurin, signaling. This study demonstrates that IGF can mediate skeletal muscle hypertrophy in a myoblast-independent fashion and suggests that muscle-specific overexpression of the IGF-1R or stimulation of its signaling pathways could be used to develop strategies to ameliorate muscle wasting without stimulating proliferative pathways leading to carcinogenesis or other pathological sequelae.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17940216     DOI: 10.1152/ajpendo.00160.2007

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  8 in total

1.  Prenatal myonuclei play a crucial role in skeletal muscle hypertrophy in rodents.

Authors:  Fuminori Kawano; Yusuke Ono; Ryo Fujita; Atsuya Watanabe; Ryo Masuzawa; Kazuhiro Shibata; Shunsuke Hasegawa; Ken Nakata; Naoya Nakai
Journal:  Am J Physiol Cell Physiol       Date:  2016-12-07       Impact factor: 4.249

2.  Is functional hypertrophy and specific force coupled with the addition of myonuclei at the single muscle fiber level?

Authors:  Rizwan Qaisar; Guillaume Renaud; Kevin Morine; Elisabeth R Barton; H Lee Sweeney; Lars Larsson
Journal:  FASEB J       Date:  2011-11-28       Impact factor: 5.191

3.  Growth hormone stimulates the collagen synthesis in human tendon and skeletal muscle without affecting myofibrillar protein synthesis.

Authors:  Simon Doessing; Katja M Heinemeier; Lars Holm; Abigail L Mackey; Peter Schjerling; Michael Rennie; Kenneth Smith; Søren Reitelseder; Anne-Marie Kappelgaard; Michael Højby Rasmussen; Allan Flyvbjerg; Michael Kjaer
Journal:  J Physiol       Date:  2009-11-23       Impact factor: 5.182

4.  Deletion of growth hormone receptors in postnatal skeletal muscle of male mice does not alter muscle mass and response to pathological injury.

Authors:  Archana Vijayakumar; Nicholas J Buffin; Emily J Gallagher; Jeffrey Blank; Yingjie Wu; Shoshana Yakar; Derek LeRoith
Journal:  Endocrinology       Date:  2013-07-16       Impact factor: 4.736

5.  Insulin-like growth factor-1 receptor is regulated by microRNA-133 during skeletal myogenesis.

Authors:  Mian-Bo Huang; Hui Xu; Shu-Juan Xie; Hui Zhou; Liang-Hu Qu
Journal:  PLoS One       Date:  2011-12-15       Impact factor: 3.240

6.  FHL1 reduces dystrophy in transgenic mice overexpressing FSHD muscular dystrophy region gene 1 (FRG1).

Authors:  Sandra J Feeney; Meagan J McGrath; Absorn Sriratana; Stefan M Gehrig; Gordon S Lynch; Colleen E D'Arcy; John T Price; Catriona A McLean; Rossella Tupler; Christina A Mitchell
Journal:  PLoS One       Date:  2015-02-19       Impact factor: 3.240

7.  MicroRNA-100 Reduced Fetal Bovine Muscle Satellite Cell Myogenesis and Augmented Intramuscular Lipid Deposition by Modulating IGF1R.

Authors:  Bilal Ahmad Mir; Elke Albrecht; Asghar Ali; Ola Hansson; Steffen Maak
Journal:  Cells       Date:  2022-01-28       Impact factor: 6.600

8.  PGC-1α and PGC-1β Increase Protein Synthesis via ERRα in C2C12 Myotubes.

Authors:  Erin L Brown; Victoria C Foletta; Craig R Wright; Patricio V Sepulveda; Nicky Konstantopoulos; Andrew Sanigorski; Paul Della Gatta; David Cameron-Smith; Anastasia Kralli; Aaron P Russell
Journal:  Front Physiol       Date:  2018-09-25       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.